Title(s):
Professor of Radiology and Radiological Science
Professor of Oncology
Professor of Oncology
Clinical Director, MRI
Appointment Phone:
410-955-6500
Primary Location:
The Johns Hopkins Hospital
Expertise:
General Radiology, Magnetic Resonance Imaging, Radiology
Education and Experience
Training
- Cairo University Medical College (Cairo )/ (1983)
Residencies
- GAP in Chronology ( ) / Residency - Theodor Bilharz Research Institute (1989)
Fellowships
- Beth Israel Medical Center (New York NY)/ Radiology (2000)
Certifications
- Diagnostic Radiology, American Board of Radiology (1998)
Locations
The Johns Hopkins Hospital
600 N. Wolfe Street
MRI Room 143
Baltimore, MD 21287
Phone: 410-955-4567
Appointment Phone: 410-955-6500
Fax: 410-955-9799
Location Map
Department / Division
-
Radiology and Radiological Science - Body MRI
Centers/Institutes
Centers / Institutes
- Department of Radiology and Radiological Science
Bio
Physician Title
Clinical Director, MRI
Awards and Honors
Mar. 2000 Gold Medal Award, for poster presentation at the 2000 SGR Annual meeting in Kauai, Hawaii
May 2000 Bronze Medal Award, for poster presentation at the 2000 ARRS Annual meeting in Washington, DC
Jun 2000 Fleischner Young Investigator Award, for outstanding research, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA
Nov 2000 RSNA Fellowship Research Trainee Prize, for the best GI presentation at the 2000 RSNA Annual meeting in Chicago, IL
Apr. 2001 Silver Medal Award, for poster presentation at the 31st Annual International Radiology meeting in Sao Paulo, Brazil
Dec. 2001 Cum Laude Award, for poster presentation entitled Is Cantlies resection line truly avascular? What the surgeon needs to know prior to formal hepatectomy at the 2001 RSNA Annual meeting in Chicago, IL
Mar. 2004 Cum Laude Award, Society of computed body tomography and magnetic resonance (SCBT/MR) for an outstanding scientific paper on cross sectional imaging. Henderson, Nevada.
Jun. 2004 Faculty Teacher of the Year, department of radiology, Johns Hopkins Hospital, Baltimore, MD.
Apr 2008 Melvin M. Figley Fellow in Radiology Journalism, ARRS 2008.
May 2000 Bronze Medal Award, for poster presentation at the 2000 ARRS Annual meeting in Washington, DC
Jun 2000 Fleischner Young Investigator Award, for outstanding research, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA
Nov 2000 RSNA Fellowship Research Trainee Prize, for the best GI presentation at the 2000 RSNA Annual meeting in Chicago, IL
Apr. 2001 Silver Medal Award, for poster presentation at the 31st Annual International Radiology meeting in Sao Paulo, Brazil
Dec. 2001 Cum Laude Award, for poster presentation entitled Is Cantlies resection line truly avascular? What the surgeon needs to know prior to formal hepatectomy at the 2001 RSNA Annual meeting in Chicago, IL
Mar. 2004 Cum Laude Award, Society of computed body tomography and magnetic resonance (SCBT/MR) for an outstanding scientific paper on cross sectional imaging. Henderson, Nevada.
Jun. 2004 Faculty Teacher of the Year, department of radiology, Johns Hopkins Hospital, Baltimore, MD.
Apr 2008 Melvin M. Figley Fellow in Radiology Journalism, ARRS 2008.
Expertise
- General Radiology
- Magnetic Resonance Imaging
- Radiology
Research
Research and Publications
Kamel IR, Bluemke DA, Ramsey BA, et al. Role of diffusion-weighted MR imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR. 2003; 181:708-710.
Li AE, Kamel IR, Rando F, et al. Using MRI to assess aortic wall thickness in the multiethnic study of atherosclerosis: distribution by race, sex, and age. AJR. 2004; 182:593-597.
Kamel IR, Hochman MG, Keogan MT, et al. Accuracy of breath-hold MR imaging in preoperative staging of organ-confined renal cell carcinoma. Journal of Computer Assisted Tomography. 2004; 28:327-332.
Kamel IR, Cohade C, Neyman E, Fishman EK, Wahl RL. Incremental value of CT in PET/CT of patients with colorectal carcinoma. Abdominal Imaging. 2004 Nov-Dec;29(6):663-8. Epub 2004 May 27.
Kamel IR, Lawler LP, Corl FM, Fishman EK. Patterns of collateral pathways in extrahepatic portal hypertension as demonstrated by multidetector row CT and advanced image processing. Journal of Computer Assisted Tomography. 2004;28:469-477.
Tekes A, Kamel IR, Imam K, et al. Dynamic MR imaging of bladder cancer: Evaluation of staging accuracy. AJR. 2005 Jan;184(1):121-7.
Fayad LM, Kamel IR, Mitchell DG, Bluemke DA. Functional MR cholangiography: diagnosis of functional abnormalities of the gallbladder and biliary tree. AJR. 2005 May;184(5):1563-71.
Fayad LM, Kawamoto S, Kamel IR, et al. Distinguishing stress fractures from pathologic fractures on cross-sectional imaging: How successful are we? AJR. 2005 Oct;185(4):915-24.
Kamel IR, Liapi E, Fishman EK. Focal nodular hyperplasia: Evaluation using 16 slice MDCT and 3D CT angiography. AJR 2006 Jun;186(6):1587-96
Kamel IR, Liapi E, Fishman EK. Incidental non-neoplastic hypervascular lesions in the non-cirrhotic liver: Diagnosis using 16 slice MDCT and 3D CT angiography. AJR 2006 Sep;187(3):682-7.
Vogel-Claussen J, Rochitte CE, Wu KC, Lima J, Kamel IR, Bluemke DA. Delayed enhancement MRI: Utility in myocardial imaging. Radiographics 2006 May-Jun;26(3):795-810.
Moff SL, Kamel IR, Eustace J, et al. Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography. Gastrointest Endosc. 2006 Aug;64(2):219-23
Kamel IR, Reyes DK, Liapi E, et al. Functional MR imaging assessment of tumor response following TheraSpheres treatment in patients with unresectable hepatocellular carcinoma. JVIR 2007; 18:49-56
Anders RA, Kamel IR. Biopsy considerations in the diagnosis of hepatic masses. Clin Gastroenterol Hepatol. 2007 May;5(5):541-4.
Dorfman JD, Schulick R, Choti MA, Geschwind JF, Kamel IR, Torbenson M, Thuluvath PJ. Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States. World J Gastroenterol. 2007 Feb 7;13(5):781-4.
Awad MA, Devgan L, Kamel IR, Torbensen M, Chota MA. Microwave ablation in a hepatic porcrine model correlation of CT and histopathologic findings. HPB 2007; 9(5): 357-62
Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JH. Assessment of metastatic breast cancer response to chemoembolization using with contrast agent enhanced and diffusion-weighted MR imaging. JVIR 2007 Aug;18(8):957-63.
Liapi E, Geschwind JH, Vossen JA, Buijs M, Georgiades CS, Bluemke DA, Kamel IR. Functional MR imaging evaluation of tumor response in patients with neuroendocrine hepatic metastases treated with transcatheter arterial chemoembolization. AJR 2008 Jan;190(1):67-73.
Vossen JA, Kamel IR, Buijs M, and Geschwind, JH. Role of functional MR imaging in assessing metastatic leiomyosarcoma response to chemoembolization. Journal of Computer Assisted Tomography 2008 May-Jun;32(3):347-52.
Kamel IR, Liapi E, Reyes D, Zahurak M, Bluemke DA, Geschwind JF. Serial early vascular and cellular changes after TACE as detected by contrast-enhanced and diffusion-weighted MR imaging in patients with unresectable HCC. Radiology. 2009; 250(2):466-473.
Juluru K, Vogel-Claussen J, Macura KJ, Kamel IR, Steever A, Bluemke DA. MR imaging in patients at risk for developing nephrogenic systemic fibrosis: protocols, practices, and imaging techniques to maximize patient safety. Radiographics. 2009 Jan-Feb;29(1):9-22.
Chang KJ, Kamel IR, Macura KJ, Bluemke DA. 3.0-T MR imaging of the abdomen: comparison with 1.5 T. Radiographics. 2008 Nov-Dec;28(7):1983-98
Bonekamp S, Clark J, Solga S, Kamel IR. Can Imaging Modalities Diagnose and Stage Hepatic Fibrosis and Cirrhosis accurately? J Hepatol. 2009 Jan;50(1):17-35.
Kamel, I.R.; Bluemke, D.A.; Eng, J.; Liapi, E.; Messersmith, W.; Reyes, D.K.; Geschwind, J.F. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol. 2006 Mar;17(3):505-512.
Anders, R.A.; Kamel, I.R. Biopsy considerations in the diagnosis of hepatic masses. Clin Gastroenterol Hepatol. 2007 May;5(5):541-544.
Buijs, M.; Kamel, I.R.; Vossen, J.A.; Georgiades, C.S.; Hong, K.; Geschwind, J.F. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. J Vasc Interv Radiol. 2007 Aug;18(8):957-963.
Dorfman, J.D.; Schulick, R.; Choti, M.A.; Geschwind, J.F.; Kamel, I.; Torbenson, M.; Thuluvath, P.J. Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States. World J Gastroenterol. 2007 Feb 7;13(5):781-784.
Kamel, I.R.; Reyes, D.K.; Liapi, E.; Bluemke, D.A.; Geschwind, J.F. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol. 2007 Jan;18(1 Pt 1):49-56.
Buijs, M.; Vossen, J.A.; Hong, K.; Georgiades, C.S.; Geschwind, J.F.; Kamel, I.R. Chemoembolization of hepatic metastases from ocular melanoma: assessment of response with contrast-enhanced and diffusion-weighted MRI. AJR Am J Roentgenol. 2008 Jul;191(1):285-289.
Chang, K.J.; Kamel, I.R.; Macura, K.J.; Bluemke, D.A. 3.0-T MR imaging of the abdomen: comparison with 1.5 T. Radiographics. 2008 Nov-Dec;28(7):1983-1998.
El-Khouli, R.H.; Geschwind, J.F.; Bluemke, D.A.; Kamel, I.R. Solitary fibrous tumor of the liver: magnetic resonance imaging evaluation and treatment with transarterial chemoembolization. J Comput Assist Tomogr. 2008 Sep-Oct;32(5):769-771.
Lee, K.H.; Liapi, E.; Vossen, J.A.; Buijs, M.; Ventura, V.P.; Georgiades, C.; Hong, K.; Kamel, I.; Torbenson, M.S.; Geschwind, J.F. Distribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy. J Vasc Interv Radiol. 2008 Oct;19(10):1490-1496.
Liapi, E.; Geschwind, J.F.; Vossen, J.A.; Buijs, M.; Georgiades, C.S.; Bluemke, D.A.; Kamel, I.R. Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization. AJR Am J Roentgenol. 2008 Jan;190(1):67-73.
Vossen, J.A.; Kamel, I.R.; Buijs, M.; Liapi, E.; Georgiades, C.S.; Hong, K.; Geschwind, J.F. Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization. J Comput Assist Tomogr. 2008 May-Jun;32(3):347-352.
Assumpcao, L.; Choti, M.; Pawlik, T.M.; Gecshwind, J.F.; Kamel, I.R. Functional MR imaging as a new paradigm for image guidance. Abdom Imaging. 2009 Nov;34(6):675-685.
Hong, K.; McBride, J.D.; Georgiades, C.S.; Reyes, D.K.; Herman, J.M.; Kamel, I.R.; Geschwind, J.F. Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. J Vasc Interv Radiol. 2009 Mar;20(3):360-367.
Jacene, H.A.; Leboulleux, S.; Baba, S.; Chatzifotiadis, D.; Goudarzi, B.; Teytelbaum, O.; Horton, K.M.; Kamel, I.; Macura, K.J.; Tsai, H.L.; Kowalski, J.; Wahl, R.L. Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy. J Nucl Med. 2009 Nov;50(11):1760-1769.
Jacobs, M.A.; Ouwerkerk, R.; Kamel, I.; Bottomley, P.A.; Bluemke, D.A.; Kim, H.S. Proton, diffusion-weighted imaging, and sodium (23Na) MRI of uterine leiomyomata after MR-guided high-intensity focused ultrasound: a preliminary study. J Magn Reson Imaging. 2009 Mar;29(3):649-656.
Kamel, I.R.; Liapi, E.; Reyes, D.K.; Zahurak, M.; Bluemke, D.A.; Geschwind, J.F. Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. Radiology. 2009 Feb;250(2):466-473.
Reyes, D.K.; Vossen, J.A.; Kamel, I.R.; Azad, N.S.; Wahlin, T.A.; Torbenson, M.S.; Choti, M.A.; Geschwind, J.F. Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J. 2009 Nov-Dec;15(6):526-532.
Ei Khouli, R.H.; Jacobs, M.A.; Mezban, S.D.; Huang, P.; Kamel, I.R.; Macura, K.J.; Bluemke, D.A. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology. 2010 Jul;256(1):64-73.
Li AE, Kamel IR, Rando F, et al. Using MRI to assess aortic wall thickness in the multiethnic study of atherosclerosis: distribution by race, sex, and age. AJR. 2004; 182:593-597.
Kamel IR, Hochman MG, Keogan MT, et al. Accuracy of breath-hold MR imaging in preoperative staging of organ-confined renal cell carcinoma. Journal of Computer Assisted Tomography. 2004; 28:327-332.
Kamel IR, Cohade C, Neyman E, Fishman EK, Wahl RL. Incremental value of CT in PET/CT of patients with colorectal carcinoma. Abdominal Imaging. 2004 Nov-Dec;29(6):663-8. Epub 2004 May 27.
Kamel IR, Lawler LP, Corl FM, Fishman EK. Patterns of collateral pathways in extrahepatic portal hypertension as demonstrated by multidetector row CT and advanced image processing. Journal of Computer Assisted Tomography. 2004;28:469-477.
Tekes A, Kamel IR, Imam K, et al. Dynamic MR imaging of bladder cancer: Evaluation of staging accuracy. AJR. 2005 Jan;184(1):121-7.
Fayad LM, Kamel IR, Mitchell DG, Bluemke DA. Functional MR cholangiography: diagnosis of functional abnormalities of the gallbladder and biliary tree. AJR. 2005 May;184(5):1563-71.
Fayad LM, Kawamoto S, Kamel IR, et al. Distinguishing stress fractures from pathologic fractures on cross-sectional imaging: How successful are we? AJR. 2005 Oct;185(4):915-24.
Kamel IR, Liapi E, Fishman EK. Focal nodular hyperplasia: Evaluation using 16 slice MDCT and 3D CT angiography. AJR 2006 Jun;186(6):1587-96
Kamel IR, Liapi E, Fishman EK. Incidental non-neoplastic hypervascular lesions in the non-cirrhotic liver: Diagnosis using 16 slice MDCT and 3D CT angiography. AJR 2006 Sep;187(3):682-7.
Vogel-Claussen J, Rochitte CE, Wu KC, Lima J, Kamel IR, Bluemke DA. Delayed enhancement MRI: Utility in myocardial imaging. Radiographics 2006 May-Jun;26(3):795-810.
Moff SL, Kamel IR, Eustace J, et al. Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography. Gastrointest Endosc. 2006 Aug;64(2):219-23
Kamel IR, Reyes DK, Liapi E, et al. Functional MR imaging assessment of tumor response following TheraSpheres treatment in patients with unresectable hepatocellular carcinoma. JVIR 2007; 18:49-56
Anders RA, Kamel IR. Biopsy considerations in the diagnosis of hepatic masses. Clin Gastroenterol Hepatol. 2007 May;5(5):541-4.
Dorfman JD, Schulick R, Choti MA, Geschwind JF, Kamel IR, Torbenson M, Thuluvath PJ. Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States. World J Gastroenterol. 2007 Feb 7;13(5):781-4.
Awad MA, Devgan L, Kamel IR, Torbensen M, Chota MA. Microwave ablation in a hepatic porcrine model correlation of CT and histopathologic findings. HPB 2007; 9(5): 357-62
Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JH. Assessment of metastatic breast cancer response to chemoembolization using with contrast agent enhanced and diffusion-weighted MR imaging. JVIR 2007 Aug;18(8):957-63.
Liapi E, Geschwind JH, Vossen JA, Buijs M, Georgiades CS, Bluemke DA, Kamel IR. Functional MR imaging evaluation of tumor response in patients with neuroendocrine hepatic metastases treated with transcatheter arterial chemoembolization. AJR 2008 Jan;190(1):67-73.
Vossen JA, Kamel IR, Buijs M, and Geschwind, JH. Role of functional MR imaging in assessing metastatic leiomyosarcoma response to chemoembolization. Journal of Computer Assisted Tomography 2008 May-Jun;32(3):347-52.
Kamel IR, Liapi E, Reyes D, Zahurak M, Bluemke DA, Geschwind JF. Serial early vascular and cellular changes after TACE as detected by contrast-enhanced and diffusion-weighted MR imaging in patients with unresectable HCC. Radiology. 2009; 250(2):466-473.
Juluru K, Vogel-Claussen J, Macura KJ, Kamel IR, Steever A, Bluemke DA. MR imaging in patients at risk for developing nephrogenic systemic fibrosis: protocols, practices, and imaging techniques to maximize patient safety. Radiographics. 2009 Jan-Feb;29(1):9-22.
Chang KJ, Kamel IR, Macura KJ, Bluemke DA. 3.0-T MR imaging of the abdomen: comparison with 1.5 T. Radiographics. 2008 Nov-Dec;28(7):1983-98
Bonekamp S, Clark J, Solga S, Kamel IR. Can Imaging Modalities Diagnose and Stage Hepatic Fibrosis and Cirrhosis accurately? J Hepatol. 2009 Jan;50(1):17-35.
Kamel, I.R.; Bluemke, D.A.; Eng, J.; Liapi, E.; Messersmith, W.; Reyes, D.K.; Geschwind, J.F. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol. 2006 Mar;17(3):505-512.
Anders, R.A.; Kamel, I.R. Biopsy considerations in the diagnosis of hepatic masses. Clin Gastroenterol Hepatol. 2007 May;5(5):541-544.
Buijs, M.; Kamel, I.R.; Vossen, J.A.; Georgiades, C.S.; Hong, K.; Geschwind, J.F. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. J Vasc Interv Radiol. 2007 Aug;18(8):957-963.
Dorfman, J.D.; Schulick, R.; Choti, M.A.; Geschwind, J.F.; Kamel, I.; Torbenson, M.; Thuluvath, P.J. Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States. World J Gastroenterol. 2007 Feb 7;13(5):781-784.
Kamel, I.R.; Reyes, D.K.; Liapi, E.; Bluemke, D.A.; Geschwind, J.F. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol. 2007 Jan;18(1 Pt 1):49-56.
Buijs, M.; Vossen, J.A.; Hong, K.; Georgiades, C.S.; Geschwind, J.F.; Kamel, I.R. Chemoembolization of hepatic metastases from ocular melanoma: assessment of response with contrast-enhanced and diffusion-weighted MRI. AJR Am J Roentgenol. 2008 Jul;191(1):285-289.
Chang, K.J.; Kamel, I.R.; Macura, K.J.; Bluemke, D.A. 3.0-T MR imaging of the abdomen: comparison with 1.5 T. Radiographics. 2008 Nov-Dec;28(7):1983-1998.
El-Khouli, R.H.; Geschwind, J.F.; Bluemke, D.A.; Kamel, I.R. Solitary fibrous tumor of the liver: magnetic resonance imaging evaluation and treatment with transarterial chemoembolization. J Comput Assist Tomogr. 2008 Sep-Oct;32(5):769-771.
Lee, K.H.; Liapi, E.; Vossen, J.A.; Buijs, M.; Ventura, V.P.; Georgiades, C.; Hong, K.; Kamel, I.; Torbenson, M.S.; Geschwind, J.F. Distribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy. J Vasc Interv Radiol. 2008 Oct;19(10):1490-1496.
Liapi, E.; Geschwind, J.F.; Vossen, J.A.; Buijs, M.; Georgiades, C.S.; Bluemke, D.A.; Kamel, I.R. Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization. AJR Am J Roentgenol. 2008 Jan;190(1):67-73.
Vossen, J.A.; Kamel, I.R.; Buijs, M.; Liapi, E.; Georgiades, C.S.; Hong, K.; Geschwind, J.F. Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization. J Comput Assist Tomogr. 2008 May-Jun;32(3):347-352.
Assumpcao, L.; Choti, M.; Pawlik, T.M.; Gecshwind, J.F.; Kamel, I.R. Functional MR imaging as a new paradigm for image guidance. Abdom Imaging. 2009 Nov;34(6):675-685.
Hong, K.; McBride, J.D.; Georgiades, C.S.; Reyes, D.K.; Herman, J.M.; Kamel, I.R.; Geschwind, J.F. Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. J Vasc Interv Radiol. 2009 Mar;20(3):360-367.
Jacene, H.A.; Leboulleux, S.; Baba, S.; Chatzifotiadis, D.; Goudarzi, B.; Teytelbaum, O.; Horton, K.M.; Kamel, I.; Macura, K.J.; Tsai, H.L.; Kowalski, J.; Wahl, R.L. Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy. J Nucl Med. 2009 Nov;50(11):1760-1769.
Jacobs, M.A.; Ouwerkerk, R.; Kamel, I.; Bottomley, P.A.; Bluemke, D.A.; Kim, H.S. Proton, diffusion-weighted imaging, and sodium (23Na) MRI of uterine leiomyomata after MR-guided high-intensity focused ultrasound: a preliminary study. J Magn Reson Imaging. 2009 Mar;29(3):649-656.
Kamel, I.R.; Liapi, E.; Reyes, D.K.; Zahurak, M.; Bluemke, D.A.; Geschwind, J.F. Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. Radiology. 2009 Feb;250(2):466-473.
Reyes, D.K.; Vossen, J.A.; Kamel, I.R.; Azad, N.S.; Wahlin, T.A.; Torbenson, M.S.; Choti, M.A.; Geschwind, J.F. Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J. 2009 Nov-Dec;15(6):526-532.
Ei Khouli, R.H.; Jacobs, M.A.; Mezban, S.D.; Huang, P.; Kamel, I.R.; Macura, K.J.; Bluemke, D.A. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology. 2010 Jul;256(1):64-73.
More Info
Languages
- English
Facebook
Twitter
Sharecare
Blogs
YouTube
RSS
Podcasts